[Update on neuro-oncology].
This paper summarizes the recent advances in the field of neuro-oncology. Improvement in the surgical procedures and radiosurgery, correlation between genetic alteration and the chemosensitivity of some primary brain tumors, definition of optimal therapeutic regimen in primary central nervous system lymphoma and better insights in the physiopathology of paraneoplastic syndrome represent the most significant contribution in the field over the past three years.
Louis
Elie
E
Service neurologie, Fédération Mazarin, hôpital Pitié-Salpêtrière, 47, bd de l'Hôpital, 75013 Paris.
Carpentier
Antoine
A
Delattre
Jean-Yves
JY
D001932:Brain Neoplasms / Q000201:enzymology / Q000556:secondary / Q000628:therapy*; D019008:Drug Resistance, Neoplasm; D005910:Glioma / Q000201:enzymology / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008527:Medulloblastoma / Q000628:therapy*; D010257:Paraneoplastic Syndromes / Q000209:etiology / Q000628:therapy